Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29147| Title: | Alemtuzumab improves outcomes in RRMS patients who switched from SC IFNB-1a: 6-year follow-up of CARE-MS I Patients (TOPAZ Study) | Authors: | Montalban, X. Barone, D. Broadley, S. Dive, D. Hupperts, R. M. Lycke, J. Massacesi, L. Naismith, R. T. Nakamura, K. Pandey, K. Schippling, S. Vermersch, P. Wiendl, H. Chung, L. Daizadeh, N. Afsar, S. VAN WIJMEERSCH, Bart |
Issue Date: | 2019 | Publisher: | WILEY | Source: | EUROPEAN JOURNAL OF NEUROLOGY, 26, p. 678-678 | Notes: | [Montalban, X.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada. [Barone, D.] Rowan Univ, Glassboro, NJ USA. [Broadley, S.] Griffith Univ, Sch Med, Gold Coast Campus, Southport, Qld, Australia. [Dive, D.] Univ Hosp Ctr Liege, Liege, Belgium. [Hupperts, R. M.] Maastricht Univ, Med Ctr, Orbis Med Ctr, Sittard, Netherlands. [Lycke, J.] Univ Gothenburg, Gothenburg, Sweden. [Massacesi, L.] Univ Florence, Florence, Italy. [Naismith, R. T.] Washington Univ, Sch Med, St Louis, MO USA. [Nakamura, K.] Cleveland Clin, Cleveland, OH 44106 USA. [Pandey, K.] Hackensack Univ Hosp, Multiple Sclerosis Care Ctr, Hackensack, NJ USA. [Schippling, S.] Univ Hosp Zurich, Neuroimmunol & Multiple Sclerosis Res, Zurich, Switzerland. [Schippling, S.] Univ Zurich, Zurich, Switzerland. [Vermersch, P.] Univ Lille, Lille, France. [Wiendl, H.] Univ Munster, Munster, Germany. [Chung, L.; Daizadeh, N.; Afsar, S.] Sanofi, Cambridge, MA USA. [Van Wijmeersch, B.] Hasselt Univ, Rehabil & MS Ctr Overpelt, BIOMED, Hasselt, Belgium. | Document URI: | http://hdl.handle.net/1942/29147 | ISSN: | 1351-5101 | e-ISSN: | 1468-1331 | ISI #: | 000474481003051 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.